Anti-inflammatory effect of spilanthol from Spilanthes acmella on murine macrophage by down-regulating LPS-induced inflammatory mediators

Journal of Agricultural and Food Chemistry

Volumn 56, Issue 7, 2008, Pages 2341-2349

  Wu, Li Chen ^a   Fan, Nien Chu ^a   Lin, Ming Hui ^a   Chu, Inn Ray ^a   Huang, Shu Jung ^a   Hu, Ching Yuan ^a   Han, Shang Yu ^a  

^a NATIONAL CHI NAN UNIVERSITY   (Taiwan)

Author keywords

Cyclooxygenase 2; Inducible nitric oxide synthase; Nuclear transcription factor B; Proinflammatory cytokine; Spilanthes acmella; Spilanthol

Indexed keywords

AMIDE; ANTIINFLAMMATORY AGENT; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ENZYME INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PLANT EXTRACT; SPILANTHOL; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; ASTERACEAE; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; MACROPHAGE; MOUSE;

AMIDES; ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTERACEAE; CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; ENZYME INHIBITORS; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NF-KAPPA B; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; PLANT EXTRACTS;

MURINAE; SPILANTHES ACMELLA;

EID: 42449121900     PISSN: 00218561     EISSN: None     Source Type: Journal    
DOI: 10.1021/jf073057e     Document Type: Article

References (65)

1. Dinarello, C. A. Interleukin-1, interleukin-1 receptors and interleukin-1 receptor antagonist. Int. Rev. Immunol. 1998, 16, 457-499.
2. Erwig, L. P.; Rees, A. J. Macrophage activation and programming and its role for macrophage function in glomerular inflammation. Kidney Blood Press. Res. 1999, 22, 21-25.
3. Nathan, C. Natural resistance and nitric oxide. Cell 1995, 82, 873-876.
4. Bingham, C. O. The pathogenesis of rheumatoid arthritis: pivotal cytokines involved in bone degradation and inflammation. J. Rheumatol. 2002, 65, 3-9.
5. Blantz, R. C.; Munger, K. Role of nitric oxide in inflammatory conditions. Nephron 2002, 90, 373-378.
6. Perner, A.; Rask-Madsen, J. Review article: the potential role of nitric oxide in chronic inflammatory bowel disorders. Aliment. Pharmacol. Ther. 1999, 13, 135-144.
7. Tracey, K. J. Tumor necrosis factor (catechin) in the biology of septic shock syndrome. Circ. Shock 1991, 35, 123-128.
8. Christopherson, K. S.; Bredt, D. S. Nitric oxide in excitable tissues: physiological roles and disease. J. Clin. InVest. 1997, 100, 2424-2429.
9. Papapetropoulos, A.; Rudic, R. D.; Sessa, W. C. Molecular control of nitric oxide synthases in the cardiovascular system. CardioVasc. Res. 1999, 43, 509-520.
10. Ohshima, H.; Bartsch, H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 1994, 305, 253-264.
11. Sautebin, L. Prostaglandins and nitric oxide as molecular targets for antiinflammatory therapy. Fitoterapia 2000, 71, S48-S57.
12. Surh, Y. J.; Chun, K. S.; Cha, H. H.; Han, S. S.; Keum, Y. S.; Park, K. K.; Lee, S. S. Molecular mechanisms underlying chemopreventive activities of antiinflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 2002, 480-481, 243-268.
13. Baldwin, A. S. The NF-kB and IkB proteins: new discoveries and insights. Annu. Rev. Immunol. 1996, 14, 649-681.
14. Mercurio, F.; Manning, A. M. Multiple signals converging on NF-kappaB. Curr. Opin. Cell Biol. 1999, 11, 226-232.
15. Chen, F.; Castrnova, V.; Shi, X.; Dermers, L. M. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation factor in the initiation of diseases. Clin. Chem. 1999, 45, 7-17.
16. Chen, Z.; Hagler, J.; Palombella, V. J.; Melandri, F.; Scherer, D.; Ballard, D.; Maniatis, T. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquinitin-proteasome pathway. Genes Dev. 1995, 9, 1586-1597.
17. Wu, Z. H.; Shi, Y.; Tibbetts, R. S.; Miyamoto, S. Molecular linkage between the kinase ATM and NF-B signaling in response to genotoxic stimuli. Science 2006, 311, 1141-1146.
18. Chen, Y. C.; Yang, L. L.; Lee, T. J. Oroxylin A inhibition of lipopolysaccharde induced iNOS and COX-2 gene expression via suppression of nuclear factor kappaB activation. Biochem. Pharmacol. 2000, 59, 1445-1457.
19. Glauser, M. P. The inflammatory cytokines. New developments in the pathophysiology and treatment of septic shock. Drugs 1996, 52, 9-7.
20. Fenton, M. J.; Golenbock, D. T. LPS-binding proteins and receptors. J. Leukocyte Biol. 1998, 64, 25-32.
21. Ley, J. P.; Blings, M.; Krammer, G.; Reinders, G.; Schmidt, C. O.; Bertram, H. J. Isolation and synthesis of acmellonate, a new unsaturated long chain 2-ketol ester from Spilanthes acmella. Nat. Prod. Res. 2006, 20, 798-804.
22. Nakatani, N.; Nagashima, M. Pungent alkamides from Spilanthes acmella L. var. oleraceae. Clark. Biosci., Biotechnol., Biochem. 1992, 56, 759-762.
23. Ramsewak, R. S.; Erickson, A. J.; Nair, M. G. Bioactive N-isobutylamides from the flower buds of Spilanthes acmella. Phytochemistry 1999, 9-732.
24. Ratnasooriya, W. D.; Pieris, K. P. P.; Samaratunga, U.; Jayakody, J. R. A. C. Diuretic activity of Spilanthes acmella flowers in rats. J. Ethnopharmacol. 2004, 91, 317-320.
25. Holetz, F. B.; Pessini, G. L.; Sanche, N. R.; Cortez, D. A. G.; Nakamura, C. V.; Filho, B. P. D. Screening of some plants used in Brazilian folk medicine for the treatment of infectious diseases. Mem. Inst. Oswaldo. Cruz. 2002, 97, 1027-1031.
26. Leal-Cardoso, J. H.; Fonteles, M. C. Pharmacological effects of essential of essential oils of plants of the northeast of Brazil. An. Acad. Bras. Cienc. 1999, 71, 207-213.
27. Yasuda, I.; Takeya, K.; Itokawa, H. The geometric structure of spilanthol. Chem. Pharm. Bull. 1980, 28, 2251-2253.
28. Rojas, J. J.; Ochoa, V. J.; Ocampo, S. A.; Muñoz, J. F. Screening for antimicrobial activity of ten medicinal plants used in Colombian folkloric medicine: a possible alternative in the treatment of non-nosocomial infections. BMC Complement Altern. Med. 2006, 6, 2-7.
29. Pitasawat, B.; Choochote, W.; Kanjanapothi, D.; Panfhong, A.; Jitpakdi, A.; Chaithong, U. Screening for larvicidal activity of ten carminative plants. Southeast Asian J. Trop. Med. Public Health 1998, 29, 660-662.
30. Abe, N.; Murata, T.; Hirota, A. Novel 1,1-diphenyl-2-picrylhydrazyl- radical scavengers, bisorbicillin and demethyltrichodimerol, from a fungus. Biosci., Biotechnol., Biochem. 1998, 62, 661-662.
31. Wu, L. C.; Chen, Y. C.; Ho, J. A.; Yang, C. S. Inhibitory effect of red koji extracts on mushroom tyrosinase. J. Agric. Food Chem. 2003, 51, 4240-4246.
32. Re, R.; Pellegrini, N. P.; Proteggente, A.; Pannala, A.; Yang, M.; Rice-Evans, C. Antioxidant activity applying an improved ABTS radical cation decolorization assay. Free Radical Biol. Med. 1999, 26, 1231-1237.
33. Carmichael, J.; DeGraff, W. G.; Gazdar, A. F.; Minna, J. D.; Mitchell, J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 1987, 47, 936-942.
34. Liao, C. H.; Sang, S.; Liang, Y. C.; Ho, C. T.; Lin, J. K. Suppression of inducible nitric oxide synthase and cyclooxygenase-2 in downregulating nuclear factor-kappa B pathway by garcinol. Mol. Carcinogenesis 2004, 41, 140-149.
35. Cheng, W. L.; Lii, C. K.; Chen, C. K.; Lin, T. H.; Liu, K. L. Contribution of conjugated linoleic acid to the suppression of inflammatory responses through the regulation of the NF-KB pathway. J. Agric. Food Chem. 2004, 52, 71-78.
36. Lemay, S.; Lebedeva, T. A.; Singh, A. K. Inhibition of cytokine gene expression by sodium salicylate in a macrophage cell line through an NF-kB-independent mechanism. Clin. Diagn. Lab. Immunol. 1999, 6, 567-572.
37. Attur, M. G.; Patel, R. N.; Patel, P. D.; Abramson, S. B.; Amin, A. R. Tetracycline up-regulates COX-2 expression and prostaglandin E2 production independent of its effect on nitric oxide. J. Immunol. 1999, 162, 3160-3167.
38. Axelsson, J.; Heimburger, O.; Stenvinkel, P. Adipose tissue and inflammation in chronic kidney disease. Contrib. Nephrol. 2006, 151, 165-174.
39. Danysz, W. Neurotoxicity as a mechanism for neurodegenerative disorders: basic and clinical aspects. Expert Opin. Invest. Drugs 2001, 10, 985-989.
40. Dick, C. A.; Brown, D. M.; Donaldson, K.; Stone, V. The role of free radicals in the toxic and inflammatory effects of four different Ultrafine particle types. Inhal. Toxicol. 2003, 15, 39-52.
41. Raner, G. M.; Cornelious, S.; Moulick, K.; Wang, Y.; Mortenson, A.; Cech, N. B. Effects of herbal products and their constituents on human cytochrome P450(2E1) activity. Food Chem. Toxicol. 2007, . [Epub ahead of print].
42. Blancke, F.; Claeys, M. J.; Jorens, P.; Vermeiren, G.; Bosmans, J.; Wuyts, F. L.; Vrints, C. J. Systemic inflammation and reperfusion injury in patients with acute myocardial infarction. Mediators Inflamm. 2005, 14, 385-389.
43. Wu, M. J.; Wang, L.; Ding, H. Y.; Weng, C. Y.; Yen, J. H. Glossogyne tenuifolia acts to inhibit inflammatory mediator production in a macrophage cell line by downregulating LPS-induced NF-κB. J. Biomed. Sci. 2004, 11, 186-199.
44. Yeom, M. J.; Lee, H. C.; Kim, G. H.; Lee, H. J.; Shim, I.; Oh, S. K.; Kang, S. K.; Hahm, D. H. Anti-arthritic effects of Ephedra sinica STAPF herb-acupuncture: inhibition of lipopolysaccharide-induced inflammation and adjuvant-induced polyarthritis. J. Pharmacol. Sci. 2006, 100, 41-50.
45. Yu, K. L.; Chou, Y. C.; Liu, C. S.; Chen, Y. J.; Yen, M. H.; Tang, C. S.; Chen, I. J. Inducible expression of NOS and COX-2 in evaluation the effects of ruyi-jinhuang gao on somatic pain-associated inflammation. J. Food Drug Anal. 2005, 13, 225-231.
46. Kim, H. K.; Cheon, B. S.; Kim, Y. H.; Kim, S. Y.; Kim, H. P. Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships. Biochem. Pharmacol. 1999, 58, 759-765.
47. Nam, N. H. Naturally occurring NF-kappaB inhibitors. Mini Rev. Med. Chem. 2006, 6, 945-951.
48. Yeung, F.; Hoberg, J. E.; Ramsey, C. S.; Keller, M. D.; Jones, D. R.; Frye, R. A.; Mayo, M. W. Modulation of NF-κB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004, 23, 2369-2380.
49. Cook, N. C.; Samman, S. Flavonoids-chemistry, metabolism, cardioprotective effects, and dietary sources. Nutr. Biochem. 1996, 7, 66-76.
50. Ikram, M. A review on the chemical and pharmacological aspects of genus Berberis. Planta Med. 1975, 28, 353-358.
51. Lee, C. H.; Chen, J. C.; Hsiang, C. Y.; Wu, S. L.; Wu, H. C.; Ho, T. Y. Berberine suppresses inflammatory agents-induced interleukin-1 beta and tumor necrosis factor-alpha productions via the inhibition of IkappaB degradation in human lung cells. Pharmacol. Res. 2007, 56, 193-201.
52. Lee, D. U.; Kang, Y. J.; Park, M. K.; Lee, Y. S.; Seo, H. G.; Kim, T. S.; et al. Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-α, iNOS, and IL-12 production in LPS-stimulated macrophages. Life Sci. 2003, 73, 1401-1412.
53. Fukuda, K.; Hibiya, Y.; Mutoh, M.; Koshiji, M.; Akao, S.; Fujiwara, H. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J. Enthopharmacol. 1999, 66, 227-233.
54. Šimánek, V. Benzophenanthridine alkaloids. In The Alkaloids; Brossi, A., Ed.; Academic Press: New York, 1985; Vol. 26, pp 185-240.
55. Chaturvedi, M. M.; Kumar, A.; Darnay, B. G.; Chainy, G. B.; Agarwal, S.; Aggarwal, B. B. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-kappaB activation, IkappaBalpha phosphorylation, and degradation. J. Biol. Chem. 1997, 272, 30129-30134.
56. Ahsan, H.; Reagan-Shaw, S.; Breur, J.; Ahmad, N. Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins. Cancer Lett. 2007, 249, 198-208.
57. Walterova, D.; Ulrichova, J.; Valka, I.; Vicar, J.; Vavreckova, C.; Taborska, E. Benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine: biological activities and dental care applications. Acta Univ. Palacki. Olomuc. Fac. Med. 1995, 139, 7-16.
58. Yang, C. W.; Chen, W. L.; Wu, P. L.; Tseng, H. Y.; Lee, S. J. Anti-inflammatory mechanisms of phenanthroindolizidine alkaloids. Mol. Pharmacol. 2006, 69, 749-58.
59. Kang, Y. J.; Seo, S. J.; Yun-Choi, H. S.; Lee, D. H.; Kim, Y. M.; Chang, K. C. A synthetic isoquinoline alkaloid, 1-(beta-naphthylmethyl)-6,7-dihydroxy- 1,2,3,4-tetrahydro- isoquinoline (YS 51), reduces inducible nitric oxide synthase expression and improves survival in a rodent model of endotoxic shock. J. Pharmacol. Exp. Ther. 2002, 301, 561-567.
60. Sancho, R.; Lucena, C.; Macho, A.; Calzado, M. A.; Bianco-Molina, M.; Minassi, A.; Appendino, G.; Muñoz, E. Immunosuppressive activity of capsaicinoids: capsiate derived from sweet peppers inhibits NF-kappaB activation and is a potent antiinflammatory compound in vivo. Eur. J. Immunol. 2002, 32, 1753-1763.
61. Kang, J. H.; Kim, C. S.; Han, I. S.; Kawada, T.; Yr, R. Capsaicin, a spicy component of hot peppers, modulates adipokine gene expression and protein release from obese-mouse adipose tissues and isolated adipocytes, and suppresses the inflammatory responses of adipose tissue macrophages. FEBS Lett. 2007, 581, 4389-4396.
62. Hinz, B.; Woelkart, K.; Bauer, R. Alkamides from Echinacea inhibit cyclooxygenase-2 activity in human neuroglioma cells. Biochem. Biophys. Res. Commun. 2007, 360, 441-446.
63. Bátkai, S.; Rajesh, M.; Mukhopadhyay, P.; Haskó, G.; Liaudet, L.; Cravatt, B. F.; Csiszár, A.; Ungvári, Z.; Pacher, P. Decreased age-related cardiac dysfunction, myocardial nitrative stress, inflammatory gene expression, and apoptosis in mice lacking fatty acid amide hydrolase. Am. J. Physiol. Heart Circ. Physiol. 2007, 293, H909-918.
64. Wang, X. W.; Liou, Y. C.; Ho, B.; Ding, J. L. An evolutionarily conserved 16-kDa thioredoxin-related protein is an antioxidant which regulates the NF-kappaB signaling pathway. Free Radical Biol. Med. 2007, 42, 247-259.
65. Borra, M. T.; Smith, B. C.; Denu, J. M. Mechanism of human SIRT1 activation by resveratrol. J. Biol. Chem. 2005, 280, 17187-17195.